Cargando…

Humanized Mice for Infectious and Neurodegenerative disorders

Humanized mice model human disease and as such are used commonly for research studies of infectious, degenerative and cancer disorders. Recent models also reflect hematopoiesis, natural immunity, neurobiology, and molecular pathways that influence disease pathobiology. A spectrum of immunodeficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dash, Prasanta K., Gorantla, Santhi, Poluektova, Larisa, Hasan, Mahmudul, Waight, Emiko, Zhang, Chen, Markovic, Milica, Edagwa, Benson, Machhi, Jatin, Olson, Katherine E., Wang, Xinglong, Mosley, R. Lee, Kevadiya, Bhavesh, Gendelman, Howard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179712/ https://www.ncbi.nlm.nih.gov/pubmed/34090462 http://dx.doi.org/10.1186/s12977-021-00557-1

Ejemplares similares

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

Animal models for studies of HIV‐1 brain reservoirs
por: Waight, Emiko, et al.
Publicado: (2022)

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
por: Machhi, Jatin, et al.
Publicado: (2020)

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
por: Araínga, Mariluz, et al.
Publicado: (2017)

Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice
por: Su, Hang, et al.
Publicado: (2021)

Multipolymer microsphere delivery of SARS-CoV-2 antigens
por: Shahjin, Farah, et al.
Publicado: (2023)

Humanized Mice for Studies of HIV-1 Persistence and Elimination
por: Zhang, Chen, et al.
Publicado: (2023)

Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice
por: Su, Hang, et al.
Publicado: (2020)

CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice
por: Dash, Prasanta K., et al.
Publicado: (2023)

Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice
por: Su, Hang, et al.
Publicado: (2019)

Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains
por: Li, Weizhe, et al.
Publicado: (2017)

Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
por: Zhou, Tian, et al.
Publicado: (2017)

Pharmacotherapeutics of SARS-CoV-2 Infections
por: Kevadiya, Bhavesh D., et al.
Publicado: (2021)

CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
por: Kevadiya, Bhavesh D., et al.
Publicado: (2020)

CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Machhi, Jatin, et al.
Publicado: (2021)

Creation of a long-acting nanoformulated dolutegravir
por: Sillman, Brady, et al.
Publicado: (2018)

HIV-1 cellular and tissue replication patterns in infected humanized mice
por: Araínga, Mariluz, et al.
Publicado: (2016)

HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice
por: Dash, Prasanta K., et al.
Publicado: (2020)

Pathways towards human immunodeficiency virus elimination
por: Dash, Prasanta K., et al.
Publicado: (2020)

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection
por: Epstein, Adrian A., et al.
Publicado: (2013)

The Immunopathobiology of SARS-CoV-2 Infection
por: Patel, Milankumar, et al.
Publicado: (2021)

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice
por: Boska, Michael D, et al.
Publicado: (2014)

Immunotherapy for Parkinson’s disease
por: Schwab, Aaron D., et al.
Publicado: (2020)

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
por: Abdelmoaty, Mai M., et al.
Publicado: (2022)

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
por: Saleh, Maamoon, et al.
Publicado: (2022)

Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice
por: Mathews, Saumi, et al.
Publicado: (2019)

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
por: Machhi, Jatin, et al.
Publicado: (2020)

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease
por: Mosley, R. Lee, et al.
Publicado: (2019)

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders
por: Anderson, Kristi M, et al.
Publicado: (2014)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice
por: Singh, Vir B., et al.
Publicado: (2016)

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
por: Kiyota, Tomomi, et al.
Publicado: (2018)

Influence of age, irradiation and humanization on NSG mouse phenotypes
por: Knibbe-Hollinger, Jaclyn S., et al.
Publicado: (2015)

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
por: Deodhar, Suyash, et al.
Publicado: (2022)

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
por: Markovic, Milica, et al.
Publicado: (2022)

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
por: Dash, Prasanta K., et al.
Publicado: (2019)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d1npffr274riah4g1o5gc6ck1n